NCT00398177 Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
| NCT ID | NCT00398177 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Lymphoma, Non-Hodgkin |
| Study Type | OBSERVATIONAL |
| Enrollment | 9,999 participants |
| Start Date | 1999-01 |
| Primary Completion | 2099-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 9,999 participants in total. It began in 1999-01 with a primary completion date of 2099-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade. * Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea). * A routine procedure for tissue collection is planned. * Ability to understand and the willingness to sign a written informed consent. Exclusion Criteria: * Patients without NHL or Hodgkin's disease
Contact & Investigator
Ronald Levy, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT00398177 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lymphoma, Non-Hodgkin. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00398177 currently recruiting?
Yes, NCT00398177 is actively recruiting participants. Contact the research team at akanegai@stanford.edu for enrollment information.
Where is the NCT00398177 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT00398177 clinical trial?
NCT00398177 is sponsored by Stanford University. The principal investigator is Ronald Levy, MD at Stanford University. The trial plans to enroll 9,999 participants.